Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

New Project to Improve Diagnosis and Treatment of Ovarian Cancer

publication date: Mar 15, 2019
 | 
author/source: Porvair Sciences Limited

 

bead-free Chromatin Immunoprecipitation


This project will involve collaboration with 5 key industrial partners - Porvair Sciences, Bruker UK, GE Healthcare UK, Axis Bio and GlaxoSmithKline (GSK). 

A new Antibody Drug Conjugates company will join the project in its second year. Antibody Drug Conjugates (ADC’s) are a powerful new class of therapeutics in medical oncology, where antibodies that target specific cancers are coupled with cytotoxic agents. The Cluster for Epigenomic and Antibody Drug Conjugate Therapeutics (CEAT) project aims to utilise novel epigenetic drugs and ADC’s to manipulate chemical compounds thus creating a new route for the treatment of ovarian cancer. 

Utilizing its proprietary Chromatrap® bead-free Chromatin Immunoprecipitation (ChIP) technology - Porvair Sciences will develop new epigenomic profiling approaches that will deliver the required advances in cutting-edge drug development and patient profiling. Using the Chromatrap® technology, Porvair Sciences will work with Swansea University and industrial partners to identify and characterise epigenetic drugs that are effective in preventing cancer development in ovarian cancer models. In addition, Porvair Sciences will support the evaluation of the Antibody Drug Conjugates (ADCs) resulting from the CEAT project.

CEAT principal investigator - Dr. Lewis Francis from Swansea University’s School of Medicine commented “Epigenetics involves chemical changes to the DNA and associated proteins that can lead to genes being turned on or off. In some cases, this can go wrong and lead to disease. Through the CEAT project, Swansea University will work closely with CEAT partners to develop drugs that can control epigenetic signals; these epigenetic drugs can be targeted specifically towards ovarian cancer cells where epigenetic changes have occurred.”

Amy Johnson, Business and Technical Development Manager at Porvair Sciences commented “We are delighted to be involved with the CEAT project. This is a great opportunity for the project to leverage our bead-free ChIP technology and expertise to be at the forefront of developing epigenetic-based cancer therapies”

Chromatrap® is a brand  of Porvair Sciences Ltd. with R&D and production laboratories based in the UK. Their extensive product range includes ChIP kits, DNA clean up kits and other innovative products for the life science market. Now cited in approaching thirty papers - Chromatrap® ChIP technology is rapidly becoming the method of choice for fast accurate ChIP assays.

 

*   CEAT has been awarded £1.2 million from the European Regional Development Fund via the Welsh Government’s SMART Expertise programme and the Welsh European Funding Office.

**  Ovarian cancer being one of the deadliest forms of cancer for women -as incidences of the disease, particularly in younger women, continue to rise. Cancer Research UK statistics show ovarian cancer is the sixth most common cancer affecting females in the UK, with around 7,300 new cases in 2015. Advanced ovarian cancer has a five-year survival rate of only 5%.  The incidence of ovarian cancer in younger women will continue to rise with a projected rate increase of 15% in the UK between 2014 and 2035 if no suitable interventions are developed and introduced into the National Health Service.

 

more about chromatrap

more news from Porviar



If you have not logged into the website then please enter your details below.



 

News Channels

 

 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 

 

 

 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events